Cargando…
BUB1, BUB1B, CCNA2, and CDCA8, along with miR-524-5p, as clinically relevant biomarkers for the diagnosis and treatment of endometrial carcinoma
BACKGROUND: Endometrial carcinoma (EC) is a malignant tumor of the female reproductive tract that has been associated with increased morbidity and mortality. This study aimed to identify biomarkers and potential therapeutic targets for EC. METHODS: A publicly available transcriptome data set compris...
Autores principales: | Hao, Qirong, Wu, Hongqin, Liu, Erniao, Wang, Lina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585751/ https://www.ncbi.nlm.nih.gov/pubmed/37853361 http://dx.doi.org/10.1186/s12885-023-11515-9 |
Ejemplares similares
-
Expression and prognosis analyses of BUB1, BUB1B and BUB3 in human sarcoma
por: Long, Zeling, et al.
Publicado: (2021) -
ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma
por: Zhang, Qiaoling, et al.
Publicado: (2022) -
The Human Homologue of Bub3 Is Required for Kinetochore Localization of Bub1 and a Mad3/Bub1-related Protein Kinase
por: Taylor, Stephen S., et al.
Publicado: (1998) -
Probing the catalytic functions of Bub1 kinase using the small molecule inhibitors BAY-320 and BAY-524
por: Baron, Anna P, et al.
Publicado: (2016) -
Distinct domains in Bub1 localize RZZ and BubR1 to kinetochores to regulate the checkpoint
por: Zhang, Gang, et al.
Publicado: (2015)